drugset / Trial / NCT03442244

Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects

NCT03442244

Phase 1 Completed 20 enrolled LEO Pharma
RandomizedSingle-groupDouble-blindOther

Summary

This trial is looking at whether the LEO 90100 foam causes irritation of the skin in healthy Japanese male adults without psoriasis. A single application of LEO 90100 foam and its vehicle will each be made to 2 body sites in 20 subjects.

Timeline

Start
2018-01-30
Primary completion
2018-02-20
Completion
2018-02-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule Topical
Subject betamethasone dipropionate Small molecule Topical

Indications